Skip to main content
Erschienen in: Supportive Care in Cancer 7/2006

01.07.2006 | Editorial

The silent symptom early satiety: a forerunner of distinct phenotypes of anorexia/cachexia syndromes

verfasst von: Florian Strasser

Erschienen in: Supportive Care in Cancer | Ausgabe 7/2006

Einloggen, um Zugang zu erhalten

Excerpt

Involuntary loss of appetite and weight are both common and complex clinical problems of patients with advanced cancer. As clinicians, we are confronted by patients’ affected enjoyment of life, debilitation, symptoms such as fatigue, weakness, early satiety, chronic nausea, and dyspnea as well as family concerns, but having pharmacological, nutritional, and behavioral interventions of limited effects. In this issue, Davis et al. provide a review about early satiety, which is a relative of, but not identical to, anorexia and chronic nausea [1]. The authors base their thoughts mainly on own data rooted in the collection of symptom checklist of 38 symptoms in 1,000 patients with advanced cancer referred to the Center for Palliative Medicine in Cleveland [2] and on the study of current literature. …
Literatur
1.
Zurück zum Zitat Davis MP, Walsh D, Lagman R, Yavuzsen T (2006) Early satiety in cancer patients: a common and important but underrecognized symptom. Support Care Cancer (in press) Davis MP, Walsh D, Lagman R, Yavuzsen T (2006) Early satiety in cancer patients: a common and important but underrecognized symptom. Support Care Cancer (in press)
2.
Zurück zum Zitat Walsh D, Donnelly S, Rybicki L (2000) The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer 8:175–179PubMedCrossRef Walsh D, Donnelly S, Rybicki L (2000) The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer 8:175–179PubMedCrossRef
3.
Zurück zum Zitat Homsi J, Walsh D, Rivera N, Rybicki LA, Nelson KA, Legrand SB, Davis M, Naughton M, Gvozdjan D, Pham H (2006) Symptom evaluation in palliative medicine: patient report vs systematic assessment. Support Care Cancer. DOI 10.1007/s00520-005-0009-2 Homsi J, Walsh D, Rivera N, Rybicki LA, Nelson KA, Legrand SB, Davis M, Naughton M, Gvozdjan D, Pham H (2006) Symptom evaluation in palliative medicine: patient report vs systematic assessment. Support Care Cancer. DOI 10.​1007/​s00520-005-0009-2
4.
Zurück zum Zitat Maltoni M, Caraceni A, Brunelli C, Broeckaert B, Christakis N, Eychmueller S, Glare P, Nabal M, Vigano A, Larkin P, De Conno F, Hanks G, Kaasa S, Steering Committee of the European Association for Palliative Care (2005) Prognostic factors in advanced cancer patients: evidence-based clinical recommendations—a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol 23:6240–6248CrossRefPubMed Maltoni M, Caraceni A, Brunelli C, Broeckaert B, Christakis N, Eychmueller S, Glare P, Nabal M, Vigano A, Larkin P, De Conno F, Hanks G, Kaasa S, Steering Committee of the European Association for Palliative Care (2005) Prognostic factors in advanced cancer patients: evidence-based clinical recommendations—a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol 23:6240–6248CrossRefPubMed
6.
Zurück zum Zitat Strasser F (2003) Pathophysiology of anorexia/cachexia syndrome. In: Doyle D, Hanks G, Cherny N, Calman K Sir (eds) Oxford textbook of palliative medicine 3rd edn (chapter 8.4.1). Oxford University Press, Oxford, pp 520–533 Strasser F (2003) Pathophysiology of anorexia/cachexia syndrome. In: Doyle D, Hanks G, Cherny N, Calman K Sir (eds) Oxford textbook of palliative medicine 3rd edn (chapter 8.4.1). Oxford University Press, Oxford, pp 520–533
7.
Zurück zum Zitat Bruera E, Belzile M, Neumann C, Harsanyi Z, Babul N, Darke A (2000) A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer. J Pain Symptom Manage 19:427–435CrossRefPubMed Bruera E, Belzile M, Neumann C, Harsanyi Z, Babul N, Darke A (2000) A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer. J Pain Symptom Manage 19:427–435CrossRefPubMed
8.
Zurück zum Zitat Cerny T, Lueftner D, Possinger K, Ernst G, Ruhstaller T, Meissner W, Ko Y-D, Schnelle M, Reif M, Strasser F, for the Cannabis-In-Cachexia-Study-Group (2003) Oral cannabis-extract versus delta-9-tetrahydrocannabinol for patients with cancer-related anorexia: a randomized, double-blind, placebo-controlled multicenter study (abstract 2934). Proc Am Soc Clin Oncol Meet 22:730 Cerny T, Lueftner D, Possinger K, Ernst G, Ruhstaller T, Meissner W, Ko Y-D, Schnelle M, Reif M, Strasser F, for the Cannabis-In-Cachexia-Study-Group (2003) Oral cannabis-extract versus delta-9-tetrahydrocannabinol for patients with cancer-related anorexia: a randomized, double-blind, placebo-controlled multicenter study (abstract 2934). Proc Am Soc Clin Oncol Meet 22:730
9.
Zurück zum Zitat Baracos VE, Le Bricon T (2000) Animal models for nutrition in cancer. Nestle Nutr Workshop Ser Clin Perform Progr 4:167–180; discussion 180–182 Baracos VE, Le Bricon T (2000) Animal models for nutrition in cancer. Nestle Nutr Workshop Ser Clin Perform Progr 4:167–180; discussion 180–182
10.
11.
Zurück zum Zitat Wolf I, Sadetzki S, Kanety H, Kundel Y, Pariente C, Epstein N, Oberman B, Catane R, Kaufman B, Shimon I (2006) Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients. Cancer 106:966–973CrossRefPubMed Wolf I, Sadetzki S, Kanety H, Kundel Y, Pariente C, Epstein N, Oberman B, Catane R, Kaufman B, Shimon I (2006) Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients. Cancer 106:966–973CrossRefPubMed
12.
Zurück zum Zitat Bruera E, Belzile M, Neumann C, Harsanyi Z, Babul N, Darke A (2000) A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer. J Pain Symptom Manage 19:427–435CrossRefPubMed Bruera E, Belzile M, Neumann C, Harsanyi Z, Babul N, Darke A (2000) A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer. J Pain Symptom Manage 19:427–435CrossRefPubMed
13.
Zurück zum Zitat Degen L, Petrig C, Studer D, Schroller S, Beglinger C (2005) Effect of tegaserod on gut transit in male and female subjects. Neurogastroenterol Motil 17:821–826CrossRefPubMed Degen L, Petrig C, Studer D, Schroller S, Beglinger C (2005) Effect of tegaserod on gut transit in male and female subjects. Neurogastroenterol Motil 17:821–826CrossRefPubMed
14.
Zurück zum Zitat Izzo AA (2004) Cannabinoids and intestinal motility: welcome to CB2 receptors. Br J Pharmacol 142:1201–1202CrossRefPubMed Izzo AA (2004) Cannabinoids and intestinal motility: welcome to CB2 receptors. Br J Pharmacol 142:1201–1202CrossRefPubMed
15.
Zurück zum Zitat Neary NM, Small CJ, Wren AM, Lee JL, Druce MR, Palmieri C, Frost GS, Ghatei MA, Coombes RC, Bloom SR (2004) Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab 89:2832–2836CrossRefPubMed Neary NM, Small CJ, Wren AM, Lee JL, Druce MR, Palmieri C, Frost GS, Ghatei MA, Coombes RC, Bloom SR (2004) Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab 89:2832–2836CrossRefPubMed
Metadaten
Titel
The silent symptom early satiety: a forerunner of distinct phenotypes of anorexia/cachexia syndromes
verfasst von
Florian Strasser
Publikationsdatum
01.07.2006
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 7/2006
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-006-0061-6

Weitere Artikel der Ausgabe 7/2006

Supportive Care in Cancer 7/2006 Zur Ausgabe

Forthcoming Meetings

Forthcoming Meetings

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.